Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT

MLA

Myriam Labopin, et al. “Long Term Impact of Hyperleukocytosis in Newly Diagnosed Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the EBMT.” American Journal of Hematology, vol. 92, May 2017, pp. 653–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8386840d1c821a098e995dfc4b3b7c72&authtype=sso&custid=ns315887.

APA

Myriam Labopin, Arnon Nagler, Patrice Chevallier, Didier Blaise, Jonathan Canaani, Anne Huynh, Jean Bourhis, Jan J. Cornelissen, Mohamad Mohty, Edouard Forcade, Anne Nihtinen, Gérard Socié, Tobias Gedde-Dahl, & Eric Deconinck. (2017). Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT. American Journal of Hematology, 92, 653–659.

Chicago

Myriam Labopin, Arnon Nagler, Patrice Chevallier, Didier Blaise, Jonathan Canaani, Anne Huynh, Jean Bourhis, et al. 2017. “Long Term Impact of Hyperleukocytosis in Newly Diagnosed Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the EBMT.” American Journal of Hematology 92 (May): 653–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8386840d1c821a098e995dfc4b3b7c72&authtype=sso&custid=ns315887.